News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
News By Date


Tuesday, July 22, 2014

Top Breaking News
ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3
Eli Lilly and Company (LLY) To Cut Up To 100 Indy Jobs, Send Some Work Overseas
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture
FDA Grants Genentech (RHHBY)’s Avastin Priority Review For Recurrent Platinum-Resistant Ovarian Cancer
Neogen Corporation (NEOG) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Agena Biosciences Appoints Peter Dansky As Chief Executive Officer
Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO
Avalanche Biotechnologies Boosts IPO As 2 More Biotechs Go Public This Week
SAGE Therapeutics Receives Fast Track Designation For Lead Compound SAGE-547 To Treat Status Epilepticus
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million

Featured Stories
Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?
How Much Will Those Allergan Inc. (AGN) Cost Cuts Really Help?
Drive to Add FDA Drug Police In India Delayed
Young Women With A Heart Attack Continue To Fare Worse Than Men, Yale University School Of Medicine Study
New Research Links Bad Diet To Loss Of Smell, Florida State University Study
Antipsychotic Drugs Linked To Slight Decrease In Brain Volume, University of Cambridge Study
Migraine Treatment Innovations Still Have Ways To Go
Probiotics May Help People With High Blood Pressure, Griffith University Study
Cardiff University Sheds New Light On Biology Underlying Schizophrenia
Brain Waves Show Learning To Read Doesn't End In Fourth Grade, Dartmouth College Study
Robert Kennedy's Dangerous Anti-Vaccine Activism
Healing The Heart With Fat?

More News
Synta Pharmaceuticals (SNTA) Announces Advancement Of Ganetespib Into Phase 3 Extension Of AML LI-1 Study For Patients With AML And High-Risk MDS
Nymox Pharmaceutical (NYMX) Announces Positive Efficacy Results In Phase 3 Repeat Injection Trial Of NX-1207 For BPH
Antares Pharma, Inc. (ATRS) Announces First Patient Dosed in Phase 3 QuickShot Study Evaluating Testosterone-Deficient Adult Males
Enrollment Commences In NeuroSigma, Inc.-Sponsored Pediatric Clinical Trial For The Treatment Of Lennox-Gastaut Syndrome
PSI CRO Launches A Global Phase 3 Rare Disease Trial
Argos Therapeutics, Inc. (ARGS) Presents Data Showing The Impact Of HIV Antigen Sequence Divergence On Durable Viral Control Following Treatment With Autologous Immune Therapy
GANYMED Pharmaceuticals AG Completes Recruitment For Randomized Phase 2 FAST Trial Of IMAB362 For Gastroesophageal Cancer
Genocea Biosciences HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses In Vaccinated Subjects
Halozyme Therapeutics, Inc. (HALO) Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer
MYOS (MYOS) Reports Positive Top-Line Clinical Study Results of Fortetropin's Muscle Building Activity in Male Subjects
Jazz Pharmaceuticals plc (JAZZ) And Concert Pharmaceuticals, Inc. (CNCE) Provide A Phase 1 Clinical Trial Update On JZP-386
Galectin Therapeutics Announces First Patient Dosed In Cohort 1 Of Phase 1B Clinical Trial Of GR-MD-02 In Combination With Ipilimumab In Metastatic Melanoma
ERYtech Pharma Announces Enrollment Of First Patient In Phase I/II Study Of ERY-ASP In Acute Lymphoblastic Leukemia In The United States
Galmed Pharmaceuticals Announces FDA Clearance Of IND Of Armachol For The Treatment Of Fatty Liver Disorders
Hemispherx Biopharma (HEB) Achieves High Ranking In Sensitivity Testing Against MERS/SARS Coronaviruses Compared To Other Drugs
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide
Precision Therapeutics, Inc. Release: Manuscript Demonstrating Chemofx Is A Predictive Marker In Ovarian Cancer Published By The British Journal Of Cancer
Sequenom Inc. (SQNM) Laboratories Presents New Data On The Enhanced Sequencing Series For The MaterniT21™ Plus Laboratory-Developed Test At 18th International Conference On Prenatal Diagnosis And Therapy
Toyohashi University of Technology Release: Evolution Of A Novel Organelle In Insects
MDxHealth, Inc. (MXDHF) Release: Underscores Importance Of Recent Confirmatory Clinical Validation Results Leading To Medicare Reimbursement Milestone
SMC Biotechnology Announces Publication Of Angiogenic Data
Broad Institute Release: International Team Sheds New Light On Biology Underlying Schizophrenia
Pressure BioSciences, Inc. (BBII) To Develop Front-End Sample Preparation For Parabase Genomics' Targeted Next Generation Sequencing Testing Platform
Envy Medical And Libbs Farmaceutica Announce Strategic Marketing, Sales And Distribution Agreement For Brazil
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma  (GALE) For Zuplenz(R) Oral Soluble Film
Coté Orphan Consulting And The ERA Consulting Group Announce A Strategic Alliance
DataDirect Networks Joins Global Alliance for Genomics And Health
MediGene AG (MDGEF.PK): Trianta Announces Extension Of Research Funding In The Transregional Collaborative Research Centre Of The German Research Foundation (DFG) For Adoptive T Cell Therapy
Neurotrope Enters Collaborative Agreement With Icahn School Of Medicine At Mount Sinai For Use Of Bryostatin-1 In The Treatment Of Niemann-Pick Disease Type C
ICON And University of Cambridge Collaborate To Deliver Educational Programme On Pricing & Market Access Strategy
Advaxis, Inc. And MedImmune (AZN) Partner On Immuno-Oncology Combination Clinical Trial
Assay Depot, Inc. Partners With Kansas City Area Life Science Institute To Create World’s First Academic Research Exchange
Arch Therapeutics Announces Collaboration With University College Cork School Of Pharmacy
SANUWAVE Health Signs Strategic Agreement With Premier Shockwave To Manage OssaTron Devices
Galena Biopharma  (GALE) Enters Into Definitive Agreement to License U.S. Rights for Zuplenz® (ondansetron) Oral Soluble Film
BioTie Therapies Corp.: Selincro Enters The Market In Spain
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Conjugate-Based Delivery Of RNA Therapeutics
Particle Sciences And Eyeon Therapeutics Receive Patent On Novel Dry Eye Technology
Sanofi Pasteur (SASY.PA) Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States
U.S. Patent Office Grants McCord Research Endothelial Cell Treatment Patent
Skystar Bio-Pharmaceutical (CGPN) Of Xi’an Raises $5 Million
MRC Technology Announces Humanization Of Anti-Tau Monoclonal Antibody For Alzheimer’s Disease Therapy
Orthocell Raises $8 Million In Oversubscribed IPO
PuraMed BioScience Partners With Operation Troop Aid To Sponsor Care Packages
New iPad App For TAP Biosystems’s ambr15 Automated Micro Bioreactor System
Zynx Health Announces Availability Of Knowledge Analyzer
Onyx Scientific Limited To Support Charity On Multiple Projects
Oraya Therapeutics Announces Rapid Expansion In Europe As More Hospitals Offer Oraya Therapy For Treating Wet AMD
Novasep Passes FDA Inspections On Two Sites
ZIOPHARM, Inc. Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And Clinical Program Update
Cytori Therapeutics, Inc. (CYTX) Technology Selected For NHLBI Funded Trial In LVAD Patients
First-half Business Figures For 2014:Sartorius AG Increases Order Intake, Sales Revenue And Profit
Vivione Biosciences Receives AOAC Certification, Positions Brand For Fast Growth In Food Industry
Access Pharmaceuticals (ACCP) Receives 510(K) FDA Marketing Clearance For ProctiGard™
Sidra To Help Qatar Grow As A Hub For Genetic Medicine
NanoViricides, Inc. (NNVC.PK) Celebrated The Grand Opening Of Its New R&D And cGMP Pilot Manufacturing Facility With Congressman Jim Himes As The Chief Guest Yesterday
Tergus Poised For Growth
Carl Zeiss Microscopy Highlights ZEN Browser Image Database
Bioo Scientific Corporation Launches 16S V1 – V3 rRNA Library Prep Kits For Bacterial Metagenomics Studies
Albany Molecular Research, Inc. (AMRI) (AMRI) To Announce Second Quarter Results
Aegerion Pharmaceuticals, Inc. (AEGR)To Announce Second Quarter 2014 Financial Results On Tuesday, July 29
Biocryst Pharmaceuticals (BCRX) To Announce Second Quarter 2014 Financial Results August 5
Bacterin Announces Preliminary Second Quarter 2014 Results
Becton, Dickinson and Company (BDX) Board Declares Dividend
Champions Oncology, Inc. (CSBR) To Announce Fourth Quarter And Year-End Financial Results On Thursday, July 24
Clovis Oncology (CLVS) To Announce Second Quarter 2014 Financial Results And Host Webcast Conference Call On August 7
Cempra, Inc. To Report Second Quarter 2014 Financial And Operating Results, And Host Conference Call And Webcast On July 29, 2014
Endocyte, Inc. (ECYT) Announces Second Quarter 2014 Earnings Conference Call
GTx, Inc. (GTXI) To Report Second Quarter 2014 Financial Results On August 5, 2014
iCAD, Inc. (ICAD) To Host Second Quarter 2014 Financial Results Conference Call On Wednesday, July 30, 2014
Jazz Pharmaceuticals plc (JAZZ) To Report 2014 Second Quarter Financial Results On August 5, 2014
MediWound (MDWD) To Host Second Quarter 2014 Financial Results Conference Call On July 31, 2014 At 8:30 A.M.
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Second Quarter 2014 Financial Results And Corporate Update Teleconference And Webcast On August 5
Semler Scientific To Report Second Quarter 2014 Financial Results And Host Conference Call On July 25, 2014
United Therapeutics Corporation (UTHR) To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014
TG Therapeutics, Inc. (MHA) Announces Second Quarter 2014 Financial Results And Business Update
WuXi PharmaTech Co., Ltd. Schedules Second-Quarter 2014 Earnings Release
XenoPort, Inc. (XNPT) To Release Second Quarter Financial Results on August 6, 2014
Viamet Pharmaceuticals Announces Appointment Of Amir Tavakkol, Ph.D., As Chief Development Officer
Cutera, Inc. (CUTR) Appoints Miguel Pardos As Executive Vice President Of International
Alliqua Biomedical (ALQA) Announces Changes to Its Board Of Directors
Dr. Neal Rouzier Joins BioTE Medical
BioDelivery Sciences International (BDSI) Appoints Charles J. Bramlage And Dr. Barry I. Feinberg To Its Board Of Directors
Clarus Therapeutics Expands Board of Directors With Appointment Of Two Pharmaceutical Industry Veterans
Outcomes and Quality Leader Dr. John D. Birkmeyer Joins Dartmouth-Hitchcock Leadership Team
Media Advisory: GenSpera's G-202 HCC Clinical Trial Presentation From 5th Asia-Pacific Primary Liver Cancer Expert (APPLE) Meeting Available
Roka Bioscience, Inc. (ROKA) (NASDAQ: ROKA) To Ring The NASDAQ Stock Market Closing Bell
Dr. Peter Geistlich Receives The 2014 Distinguished Humanitarian Award From Loma Linda University
Infinity Pharmaceuticals Inc. (INFI) To Participate In The BMO Capital Markets 3RD Annual Biotech Corporate Access Day
Amarillo Biosciences (AMAR) And BSI Proudly Announce Biotechnology Industry Organization (BIO) CEO & President Jim Greenwood As Panelist For 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit At United Nations
Cancer Genetics, Inc. (CGIX) To Present At The Canaccord Genuity 34th Annual Growth Conference
BioSpecifics Technologies Corporation (BSTC) (NASDAQ: BSTC) To Ring The NASDAQ Stock Market Opening Bell
Pluristem Therapeutics (PSTI) To Host Investor Breakfast And Webcast On July 23 In New York City
Seegene, Inc. To Unveil At AACC 2014 The Innovative Real-Time PCR Technology That Doubles The Channel Availability Of Any Real-Time PCR Instrument
Cambridge-Based Broad Institute To Receive Largest Gift Worldwide: $650 Million